Table 1.
Summary of COVID-19 convalescent plasma characteristics
| Sample ID | S-protein trimer-binding titer | RBD-binding titer | S1-binding titer | S2-binding titer | Neutralization titer WT | Neutralization titer D614G | Neutralization titer PT188-EM |
| PT003 | 1/320 | 1/10 | 1/80 | 1/320 | 1/15 | Not neutralizing | Not neutralizing |
| PT004 | 1/2,560 | 1/80 | 1/320 | 1/2,560 | 1/120 | 1/60 | 1/20 |
| PT005 | 1/320 | 1/80 | 1/160 | 1/1,280 | 1/80 | 1/30 | 1/10 |
| PT006 | 1/640 | 1/160 | 1/1,280 | 1/640 | 1/120 | 1/20 | 1/10 |
| PT008 | 1/10,240 | 1/80 | 1/640 | 1/640 | 1/120 | 1/80 | 1/40 |
| PT009 | 1/10,240 | 1/2,560 | 1/1,280 | 1/2,560 | 1/640 | 1/320 | 1/120 |
| PT010 | 1/320 | 1/80 | 1/80 | 1/2,560 | 1/15 | 1/10 | 1/10 |
| PT012 | 1/1,280 | 1/160 | 1/320 | 1/320 | 1/120 | 1/80 | 1/15 |
| PT014 | 1/1,280 | 1/80 | 1/160 | 1/1,280 | 1/120 | 1/40 | 1/20 |
| PT015 | 1/10,240 | 1/10,240 | 1/2,560 | 1/5,120 | 1/640 | 1/320 | 1/160 |
| PT041 | 1/640 | 1/40 | 1/160 | 1/80 | 1/40 | 1/10 | 1/10 |
| PT042 | 1/5,120 | 1/320 | 1/1,280 | 1/5,120 | 1/960 | 1/320 | 1/60 |
| PT100 | 1/1,280 | 1/80 | 1/160 | 1/1,280 | 1/80 | 1/30 | 1/40 |
| PT101 | 1/640 | 1/40 | 1/160 | 1/320 | 1/20 | 1/10 | 1/10 |
| PT102 | 1/160 | 1/20 | 1/80 | 1/640 | 1/10 | Not neutralizing | Not neutralizing |
| PT103 | 1/160 | Not binder | Not binder | 1/160 | Not neutralizing | Not neutralizing | Not neutralizing |
| PT122 | 1/10,240 | 1/1,280 | 1/1,280 | 1/2,560 | 1/640 | 1/480 | 1/320 |
| PT188 | 1/10,240 | 1/1,280 | 1/5,120 | 1/5,120 | 1/10,240 | 1/10,240 | 1/40 |
| PT200 | 1/1,280 | Not binder | 1/160 | 1/10,240 | 1/60 | 1/30 | Not neutralizing |
| PT276 | 1/80 | Not binder | 1/80 | 1/320 | Not neutralizing | Not neutralizing | Not neutralizing |
The table shows the binding profile and neutralization activities of 20 COVID-19 convalescent plasma samples.